人类嗜T淋巴细胞病毒1型与献血
HTLV-1 and blood donation.
作者信息
Murphy Edward L
机构信息
Departments of Laboratory Medicine and Epidemiology/Biostatistics, University of California San Francisco, San Francisco, California, USA.
Vitalant Research Institute, San Francisco, California, USA.
出版信息
Br J Haematol. 2024 Jan;204(1):29-30. doi: 10.1111/bjh.19051. Epub 2023 Aug 14.
Abstract
Human T-cell leukaemia virus type 1 (HTLV-1) is a human retrovirus that causes adult T-cell lymphoma and HTLV-associated myelopathy. In this issue, Rosadas et al. use data from a recent WHO report to describe how blood banks test for HTLV-1 and how this testing contributes to public health surveillance for the virus. Commentary on: Rosadas et al. HTLV-1 screening of blood donations: we are systematically missing opportunities. Br J Haematol 2023;202:1220-1223.
摘要
人类嗜T淋巴细胞病毒1型（HTLV-1）是一种人类逆转录病毒，可导致成人T细胞淋巴瘤和HTLV相关脊髓病。在本期中，罗萨达斯等人利用世界卫生组织最近一份报告中的数据，描述了血库如何检测HTLV-1以及这种检测如何有助于对该病毒进行公共卫生监测。评论文章：罗萨达斯等人。献血中的HTLV-1筛查：我们正系统性地错失机会。《英国血液学杂志》2023年；202:1220 - 1223。
相似文献
1
HTLV-1 and blood donation.人类嗜T淋巴细胞病毒1型与献血
Br J Haematol. 2024 Jan;204(1):29-30. doi: 10.1111/bjh.19051. Epub 2023 Aug 14.
2
HTLV-1 screening of blood donations: We are systematically missing opportunities.献血中的人类嗜T淋巴细胞病毒1型（HTLV-1）筛查：我们正系统性地错失机会。
Br J Haematol. 2023 Sep;202(6):1220-1223. doi: 10.1111/bjh.18988. Epub 2023 Jul 24.
3
Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1).人类嗜T淋巴细胞病毒1型（HTLV-1）的分子生物学与发病机制
Int J Exp Pathol. 2001 Jun;82(3):135-47. doi: 10.1046/j.1365-2613.2001.00191.x.
4
Human T-cell leukaemia virus type 1: parasitism and pathogenesis.人类1型T细胞白血病病毒：寄生与发病机制
Philos Trans R Soc Lond B Biol Sci. 2017 Oct 19;372(1732). doi: 10.1098/rstb.2016.0272.
5
HTLV-1 clonality in adult T-cell leukaemia and non-malignant HTLV-1 infection.成人T细胞白血病和非恶性HTLV-1感染中的HTLV-1克隆性
Semin Cancer Biol. 2014 Jun;26:89-98. doi: 10.1016/j.semcancer.2013.11.003. Epub 2013 Dec 6.
6
Human T-cell Leukemia Virus Type 1 (HTLV-1)-induced Uveitis.人类 T 细胞白血病病毒 1 型（HTLV-1）相关性葡萄膜炎。
Ocul Immunol Inflamm. 2023 Sep;31(7):1416-1424. doi: 10.1080/09273948.2023.2175697. Epub 2023 Feb 21.
7
Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection.人类 T 淋巴细胞嗜病毒 1 型感染的临床和公共卫生意义。
Clin Microbiol Rev. 2022 Apr 20;35(2):e0007821. doi: 10.1128/cmr.00078-21. Epub 2022 Feb 23.
8
Comparative virology of HTLV-1 and HTLV-2.HTLV-1 和 HTLV-2 的比较病毒学。
Retrovirology. 2019 Aug 7;16(1):21. doi: 10.1186/s12977-019-0483-0.
9
Integrated molecular and immunological features of human T-lymphotropic virus type 1 infection and disease progression to adult T-cell leukaemia or lymphoma.人类 T 淋巴细胞白血病病毒 1 型感染的综合分子和免疫特征及其向成人 T 细胞白血病或淋巴瘤的疾病进展。
Lancet Haematol. 2023 Jul;10(7):e539-e548. doi: 10.1016/S2352-3026(23)00087-X.
10
HTLV-1 and leukemogenesis: virus-cell interactions in the development of adult T-cell leukemia.人类嗜T淋巴细胞病毒1型（HTLV-1）与白血病发生：成人T细胞白血病发展过程中的病毒-细胞相互作用
Recent Results Cancer Res. 2014;193:191-210. doi: 10.1007/978-3-642-38965-8_11.
本文引用的文献
1
HTLV-1 screening of blood donations: We are systematically missing opportunities.献血中的人类嗜T淋巴细胞病毒1型（HTLV-1）筛查：我们正系统性地错失机会。
Br J Haematol. 2023 Sep;202(6):1220-1223. doi: 10.1111/bjh.18988. Epub 2023 Jul 24.
2
The prevalence of human T-lymphotropic virus type 1 & 2 (HTLV-1/2) in South African blood donors.南非献血者中人类 T 淋巴细胞白血病病毒 1 型和 2 型（HTLV-1/2）的流行率。
Vox Sang. 2019 Jul;114(5):451-458. doi: 10.1111/vox.12778. Epub 2019 Apr 4.
3
Epidemiology of donors and recipients: lessons from the SCANDAT database.供体与受体的流行病学：来自SCANDAT数据库的经验教训。
Transfus Med. 2019 Apr;29 Suppl 1:6-12. doi: 10.1111/tme.12487. Epub 2017 Nov 16.
4
Incidence of human T-lymphotropic virus 1 infection in adolescent and adult blood donors in Japan: a nationwide retrospective cohort analysis.在日本，青少年和成年献血者中人类 T 淋巴细胞病毒 1 感染的发生率：一项全国性回顾性队列分析。
Lancet Infect Dis. 2016 Nov;16(11):1246-1254. doi: 10.1016/S1473-3099(16)30252-3. Epub 2016 Aug 23.
5
The National Heart, Lung, and Blood Institute Recipient Epidemiology and Donor Evaluation Study (REDS-III): a research program striving to improve blood donor and transfusion recipient outcomes.美国国立心肺血液研究所受者流行病学和供者评估研究（REDS-III）：一个旨在改善献血者和输血受者结局的研究计划。
Transfusion. 2014 Mar;54(3 Pt 2):942-55. doi: 10.1111/trf.12468. Epub 2013 Nov 4.
6
Donor testing and risk: current prevalence, incidence, and residual risk of transfusion-transmissible agents in US allogeneic donations.供者检测与风险：美国异基因捐献中输血传播病原体的当前流行率、发生率和残余风险。
Transfus Med Rev. 2012 Apr;26(2):119-28. doi: 10.1016/j.tmrv.2011.07.007. Epub 2011 Aug 25.
7
Patterns of HTLV-I infection among family members of patients with adult T-cell leukemia/lymphoma and HTLV-I associated myelopathy/tropical spastic paraparesis.成人T细胞白血病/淋巴瘤及人类嗜T淋巴细胞病毒I型相关脊髓病/热带痉挛性截瘫患者家庭成员中的人类嗜T淋巴细胞病毒I型感染模式
Int J Cancer. 1996 Jan 17;65(2):272-3. doi: 10.1002/(SICI)1097-0215(19960117)65:2<272::AID-IJC23>3.0.CO;2-E.
8
A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients.成人T细胞白血病病毒输血传播的回顾性研究：受血者血清阳转情况
Vox Sang. 1984;46(5):245-53. doi: 10.1111/j.1423-0410.1984.tb00083.x.
Zotero 插件